APA (7th ed.) Citation

Kim, T., Hao, C., Pan, M., Ganjoo, K. N., & Bui, N. Q. Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center. MDPI AG.

Chicago Style (17th ed.) Citation

Kim, Ted, Clara Hao, Minggui Pan, Kristen N. Ganjoo, and Nam Q. Bui. Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center. MDPI AG.

MLA (9th ed.) Citation

Kim, Ted, et al. Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center. MDPI AG.